Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

311 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[The effects of hormone replacement therapy on mind and brain].
Baldinger P, Kranz G, Höflich A, Savli M, Stein P, Lanzenberger R, Kasper S. Baldinger P, et al. Among authors: lanzenberger r. Nervenarzt. 2013 Jan;84(1):14-9. doi: 10.1007/s00115-011-3456-7. Nervenarzt. 2013. PMID: 22318360 Review. German.
[Neuroimaging in schizophrenia].
Lanzenberger R, Kasper S. Lanzenberger R, et al. Fortschr Neurol Psychiatr. 2005 Nov;73 Suppl 1:S51-9. doi: 10.1055/s-2005-915581. Fortschr Neurol Psychiatr. 2005. PMID: 16270245 Review. German.
In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy subjects administered different doses of escitalopram or citalopram.
Klein N, Sacher J, Geiss-Granadia T, Attarbaschi T, Mossaheb N, Lanzenberger R, Pötzi C, Holik A, Spindelegger C, Asenbaum S, Dudczak R, Tauscher J, Kasper S. Klein N, et al. Among authors: lanzenberger r. Psychopharmacology (Berl). 2006 Oct;188(3):263-72. doi: 10.1007/s00213-006-0486-0. Epub 2006 Sep 6. Psychopharmacology (Berl). 2006. PMID: 16955282 Clinical Trial.
Higher serotonin transporter occupancy after multiple dose administration of escitalopram compared to citalopram: an [123I]ADAM SPECT study.
Klein N, Sacher J, Geiss-Granadia T, Mossaheb N, Attarbaschi T, Lanzenberger R, Spindelegger C, Holik A, Asenbaum S, Dudczak R, Tauscher J, Kasper S. Klein N, et al. Among authors: lanzenberger r. Psychopharmacology (Berl). 2007 Apr;191(2):333-9. doi: 10.1007/s00213-006-0666-y. Epub 2007 Jan 19. Psychopharmacology (Berl). 2007. PMID: 17235610 Clinical Trial.
Differences in the dynamics of serotonin reuptake transporter occupancy may explain superior clinical efficacy of escitalopram versus citalopram.
Kasper S, Sacher J, Klein N, Mossaheb N, Attarbaschi-Steiner T, Lanzenberger R, Spindelegger C, Asenbaum S, Holik A, Dudczak R. Kasper S, et al. Among authors: lanzenberger r. Int Clin Psychopharmacol. 2009 May;24(3):119-25. doi: 10.1097/YIC.0b013e32832a8ec8. Int Clin Psychopharmacol. 2009. PMID: 19367152 Review.
The serotonin-1A receptor in anxiety disorders.
Akimova E, Lanzenberger R, Kasper S. Akimova E, et al. Among authors: lanzenberger r. Biol Psychiatry. 2009 Oct 1;66(7):627-35. doi: 10.1016/j.biopsych.2009.03.012. Epub 2009 May 7. Biol Psychiatry. 2009. PMID: 19423077 Review.
311 results